Diagnostic performance of DSC perfusion MRI to distinguish tumor progression and treatment-related changes: a systematic review and meta-analysis.

Fu, Rongwei; Szidonya, Laszlo; Barajas, Ramon F; Ambady, Prakash; Varallyay, Csanad; Neuwelt, Edward A

Fu, Rongwei; Szidonya, Laszlo; Barajas, Ramon F; Ambady, Prakash; Varallyay, Csanad; Neuwelt, Edward A.

Afiliación

Fu R; Oregon Health & Science University-Portland State University, School of Public Health, Portland, Oregon, USA.
Szidonya L; Department of Medical Informatics & Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USA.
Barajas RF; Department of Radiology, Oregon Health & Science University, Portland, Oregon, USA.
Ambady P; Neuro-Oncology Program, Oregon Health & Science University, Portland, Oregon, USA.
Varallyay C; Heart and Vascular Center, Diagnostic Radiology, Semmelweis University, Budapest, Hungary.
Neuwelt EA; Department of Radiology, Oregon Health & Science University, Portland, Oregon, USA.

Neurooncol Adv ; 4(1): vdac027, 2022.

Article en En | MEDLINE | ID: mdl-35386567

Palabras clave

diagnostic performance; dynamic susceptibility contrast (DSC) MRI; high-grade glioma; meta-analysis; treatment-related changes

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Systematic_reviews Idioma: En Revista: Neurooncol Adv Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google